Atherosclerosis: A manifestation of chronic iron toxicity?

Vascular Medicine

Volumn 8, Issue 3, 2003, Pages 153-155

  Zacharski, Leo R ^a,b,c   Gerhard, Glenn S ^a,b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b VA MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL STUDY; CLINICAL TRIAL; FERRITIN BLOOD LEVEL; GENE MUTATION; HEART INFARCTION; HEMOCHROMATOSIS; HUMAN; IRON CHELATION; IRON METABOLISM; IRON OVERLOAD; IRON RESTRICTION; IRON STORAGE; OUTCOMES RESEARCH; OXIDATIVE STRESS; PATHOGENESIS; PHLEBOTOMY; PRIORITY JOURNAL;

ARTERIOSCLEROSIS; CHRONIC DISEASE; HUMANS; IRON; IRON OVERLOAD;

EID: 1242340467     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1191/1358863x03vm492ed     Document Type: Article

References (20)

1. Sullivan JL. Iron and sex difference in heart disease risk. Lancet 1981: i: 1293-94.
2. Zacharski LR, Ornstein DL, Woloshin S, Schwartz LM. Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am Heart J 2000: 140: 98-104.
3. Zacharski LR, Chow B, Lavori PW et al. The iron (Fe) and atherosclerosis study (FeAST): a pilot study of reduction of body iron stores in atherosclerotic peripheral vascular disease. Am Heart J 2000; 139: 337-45.
4. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 1997; 96: 3300-307.
5. Kakhlon O, Cabantchik ZI. The labile iron pool: characterization, measurement, and participation in cellular processes. Free Radic Biol Med 2002; 33: 1037-46.
6. Rasmussen ML, Folsom AR, Catellier DJ, Tsai MY, Garg U, Eckfeldt JH. A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2001; 154: 739-46.
7. Gerhard GS, Kaufmann EJ. Wang X et al. Genetic differences in hepatic lipid peroxidation potential and iron levels in mice. Mech Ageing Dev 2002; 123: 167-76.
8. Bomford A. Genetics of haemochromatosis. Lancet 2002; 360: 1673-81.
9. Salonen JT, Korpela H, Nyyssonen K et al. Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: a randomized cross-over trial in male smokers. J Intern Med 1995; 237: 161-68.
10. Van Jaarsveld J, Pool GF. Beneficial effects of blood donation on high density lipoprotein concentration and the oxidative potential of low density lipoprotein. Atherosclerosis 2002; 16: 395-402.
11. Facchini FS, Saylor KL. Effect of iron depletion on cardiovascular risk factors. Studies in carbohydrate-intolerant patients. Ann N Y Acad Sci 2002; 967: 342-51.
12. Facchini FS, Hua NW, Stoohs RA. Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology 2002; 122: 931-39.
13. Fernandez-Real JM, Penarroja G, Castro A, Garcia-Bragado F, Hernandez-Aguado I, Ricart W. Blood letting in high-ferritin type 2 diabetes. Effects on insulin sensitivity and b-cell function. Diabetes 2002; 51: 1000-1004.
14. Bofill C, Joven J, Bages J et al. Response to repeated phlebotomies in patients with non-insulin-dependent diabetes mellitus. Metabolism 1994; 43: 614-20.
15. Guillygomarc'h A, Mendler MH, Moirand R et al. Venesection therapy of insulin resistance-associated hepatic iron overload. J Hepatol 2001; 23: 344-49.
16. Duffy SJ, Biegelsen ES, Holbrook M, Russell JD, Gokce JK Jr. Iron chelation improves endothelial function in patients with coronary artery disease. Circulation 2001; 103: 2799-804.
17. Failla M, Giannattasio C, Piperno A et al. Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy. Hepatology 2000; 1: 569-73.
18. Gaenzer H, Marschang P, Sturm W et al. Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol 2002; 1: 2189-94.
19. Meyers DG, Jensen KC, Menitove JE. A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events. Transfusion 2002; 42: 1135-39.
20. Grady D. Postmenopausal hormones - therapy for symptoms only. N Engl J Med 2003; 348: 1835-37.